Cargando…
Secondary Bacterial Infections in Mucormycosis-COVID-19 Cases: Experience during the Second COVID-19 Wave in India
In the second wave of COVID-19 in India, there was a new challenge in the form of mucormycosis. Coinfection with mucormycosis was perilous as both conditions required a prolonged hospital stay, thus serving as an ideal platform for secondary infections. Using a retrospective observational study, we...
Autores principales: | Sharad, Neha, Srivastava, Smriti, Singh, Parul, Puraswani, Mamta, Srivastav, Sharad, Malhotra, Rajesh, Trikha, Anjan, Mathur, Purva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769615/ https://www.ncbi.nlm.nih.gov/pubmed/36301096 http://dx.doi.org/10.1128/spectrum.00919-22 |
Ejemplares similares
-
P282 Bacterial co-infections in Mucormycosis infected COVID-19 patients: experience from a tertiary care center in India
por: Sharad, Neha, et al.
Publicado: (2022) -
Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance
por: Khurana, Surbhi, et al.
Publicado: (2021) -
High Prevalence of Fungal and NDM-OXA Producing Gram-Negative Bacterial Superinfections in the Second Wave of Coronavirus Disease 2019 in India: Experience from a Dedicated Coronavirus Disease 2019 Hospital in North India
por: Katoch, Omika, et al.
Publicado: (2022) -
P150 Profile of Candidemia in a national level HAI Surveillance Network of India
por: Srivastav, Sharad, et al.
Publicado: (2022) -
Clinical Validation of Standard Q COVID-19 Antigen and IgM/IgG Combo Kit Assay at a Tertiary Care Center in Northern India
por: Singh, Parul, et al.
Publicado: (2022)